Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study

This publication has 10 references indexed in Scilit:

• Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS)
  Lung Cancer, 2018
• 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
  Annals of Oncology, 2014
• The 2014 Surgeon General's Report: Commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and Updating the Evidence on the Health Consequences of Cigarette Smoking
  American Journal of Epidemiology, 2014
• Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
  British Journal of Cancer, 2013
• Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
  Annals of Oncology, 2013
• Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?
  Therapeutic Advances in Medical Oncology, 2013
• Evolving characteristics of lung cancer: a surgical appraisal
  European Journal of Cardio-Thoracic Surgery, 2012
• Adjuvant Chemotherapy for Non-small Cell Lung Cancer: Practice Patterns and Outcomes in the General Population of Ontario, Canada
  Journal of Thoracic Oncology, 2012
• Preoperative versus Postoperative Chemotherapy in Patients with Resectable Non-small Cell Lung Cancer: Systematic Review and Indirect Comparison Meta-Analysis of Randomized Trials
  Journal of Thoracic Oncology, 2009
• Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer
  Chest, 2005